Buchumschlag

Correction to “Setmelanotide in Bardet‐Biedl Syndrome: A 52‐Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort”

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Obesity
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Setmelanotide in Bardet‐Biedl Syndrome: A 52‐Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort
von: Jesús Argente, et al.
Veröffentlicht: (2026)

Hyperphagia in Bardet–Biedl syndrome: Pathophysiology, burden, and management
von: Philip L. Beales, et al.
Veröffentlicht: (2025)

Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction
von: Jeremy W. Tomlinson
Veröffentlicht: (2024)

Bardet‐Biedl syndrome: A clinical overview focusing on diagnosis, outcomes and best‐practice management
von: Ashley Shoemaker
Veröffentlicht: (2024)

Clinical burden of hyperphagia, obesity and health outcomes in paediatric individuals with Bardet‐Biedl syndrome: A CRIBBS data analysis
von: Jeremy Pomeroy, et al.
Veröffentlicht: (2025)

Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency
von: Ellina Lytvyak, et al.
Veröffentlicht: (2026)

Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study
von: Harold E. Bays, et al.
Veröffentlicht: (2026)

Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE ‐ JP Trial
von: Koutaro Yokote, et al.
Veröffentlicht: (2026)

Correction to “Association of Cardiovascular‐Kidney‐Syndrome and Brain Macrostructure and Microstructure Injury: A Prospective Cohort Study”
Veröffentlicht: (2026)

Effect of Sevelamer and B. longum on Insulin Sensitivity in Participants With Obesity: A Randomized Clinical Trial
von: Eric Baeuerle, et al.
Veröffentlicht: (2026)

Efficacy and Safety of Tirzepatide in Japanese Participants With Obesity: A Subpopulation Analysis of the SURMOUNT ‐1 Trial
von: Yasushi Ishigaki, et al.
Veröffentlicht: (2026)

Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT ‐1 Over 176 Weeks
von: Hiddo J. L. Heerspink, et al.
Veröffentlicht: (2026)

Association Between Metabolic Syndrome and Incident Cervical Cancer: A Retrospective Cohort Study
von: Linjun Jiang, et al.
Veröffentlicht: (2025)

ObesityWeek ® 2025—Reflecting on an Exciting Time in Obesity Research and Treatment
von: Susan Z. Yanovski, et al.
Veröffentlicht: (2026)

The Supportive Effect of Acarbose to Orlistat in Weight Management—A Randomized, Double‐Blind, Multiarm Phase 2 Trial
von: Ulf Holmbäck, et al.
Veröffentlicht: (2025)

Association of Cardiovascular‐Kidney‐Syndrome and Brain Macrostructure and Microstructure Injury: A Prospective Cohort Study
von: Guanyu Niu, et al.
Veröffentlicht: (2026)

Effectiveness of Telemedicine Prescribing and a Long‐Acting Obesity Medication Behavioral Program: A 24‐Week Single‐Arm Study
von: Leslie J. Heinberg, et al.
Veröffentlicht: (2025)

Efficacy and Safety of Once‐Weekly and Once‐Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta‐Analysis of Clinical Trials
von: Ricardo Amaral, et al.
Veröffentlicht: (2026)

Testing a Personalized Behavioral Weight Loss Approach Using Multifactor Prescriptions and Self‐Experimentation: 12‐Week mHealth Pilot Randomized Controlled Trial Results
von: Caitlin E. Martinez, et al.
Veröffentlicht: (2025)

Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP Trial
von: Faith Anne N. Heeren, et al.
Veröffentlicht: (2025)

Long‐term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial
von: Soo Heon Kwak, et al.
Veröffentlicht: (2024)

Negative Consequences of Removing GLP‐1 RA Obesity Coverage: A Cross‐Sectional Cohort Comparison Study
von: Jackson M. Francis, et al.
Veröffentlicht: (2026)

Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
von: Sheila Pintado-Cucarella
Veröffentlicht: (2016)

Discontinuation of SGLT2i After a Urogenital Infection: A Population‐Based Matched Cohort Study of Patients With Type 2 Diabetes
von: Christine Ljungberg, et al.
Veröffentlicht: (2026)

GLP‐1 RA Use and Weight Loss Among Patients in a Weight Navigation Program Versus Primary Care: A Matched Cohort Study
von: Dina H. Griauzde, et al.
Veröffentlicht: (2026)

Longitudinal Improvements in Health‐Related Quality of Life Among Children Enrolled in the CANadian Paediatric Weight Management Registry ( CANPWR ) Over 3 Years
von: Marina Ybarra, et al.
Veröffentlicht: (2026)

Genetic Risk Scores for Obesity and the Effectiveness of a Diet and Exercise Intervention Program: A Historical Cohort Study
von: Sho Nakamura, et al.
Veröffentlicht: (2025)

Effect of Metformin Treatment on Gonadotropin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis of 51 Randomised Controlled Trials
von: Robert Krysiak, et al.
Veröffentlicht: (2026)

Diabetes screening outcomes in youth presenting for paediatric weight management: A report of the Paediatric Obesity Weight Evaluation Registry
von: Seema Kumar, et al.
Veröffentlicht: (2024)

Impact of Sleeve Gastrectomy Versus Intensive Lifestyle Modifications With Obesity Management Medications on BMI Trajectory and Target Attainment: A Prospective Matched Cohort Study
von: Maria Francesca Russo, et al.
Veröffentlicht: (2026)

Addition of Phentermine‐Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double‐Blind Randomized Clinical Trial
von: Alejandro Campos, et al.
Veröffentlicht: (2026)

Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023
von: Olajide A. Adekunle, et al.
Veröffentlicht: (2026)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials
von: Minna Brændholt Olsen, et al.
Veröffentlicht: (2026)

Cardiovascular Indexes and Oxidative Balance in Advanced Cardiovascular–Kidney–Metabolic Syndrome
von: Zhaoqi Yan, et al.
Veröffentlicht: (2025)

Simplified Switching to Once‐Weekly Insulin Icodec Without an Initial One‐Time Additional Dose Versus Once‐Daily Insulin Glargine U100 in Basal Insulin‐Treated Type 2 Diabetes ( ONWARDS 10): A Randomised Controlled Trial
von: Julio Rosenstock, et al.
Veröffentlicht: (2026)

Early‐Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials
von: Evgenia Gourgari, et al.
Veröffentlicht: (2025)

One‐Year Weight Loss Following a Remote Culinary Medicine Program: A Bi‐Center Randomized Controlled Trial
von: Rani Polak, et al.
Veröffentlicht: (2026)

Effect of Zoledronic Acid on Skeletal Muscle After Bariatric Surgery: A Secondary Analysis From a Randomized Controlled Trial
von: Søren Gam, et al.
Veröffentlicht: (2025)

Disparities in Adolescent and Young Adult Obesity Medication Dispensing: A Retrospective Linked EHR ‐Pharmacy Cohort, 2020–2025
von: Isa Granados, et al.
Veröffentlicht: (2026)

Weight Changes From Glucagon‐Like Peptide‐1 Receptor Agonist Use and Discontinuation: A Retrospective Cohort Study
von: G. Caleb Alexander, et al.
Veröffentlicht: (2025)